Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Survival results in five malignant neoplasms separated by a decade at Institut C...
Journal Information
Vol. 150. Issue 4.
Pages 138-140 (February 2018)
Download PDF
More article options
Vol. 150. Issue 4.
Pages 138-140 (February 2018)
Brief report
Survival results in five malignant neoplasms separated by a decade at Institut Català d’Oncologia, Spain
Resultados de supervivencia en cinco neoplasias malignas separados por una década en el Institut Català d’Oncologia
José Ramón Germá-Lluch
Corresponding author

Corresponding author.
, Lourdes Petriz, Pau Lopez, Esther Asensio
Oficina de Resultados Oncológicos (ORO), Dirección de Estrategia Clínica, Investigación y Resultados Clínicos, Institut Català d’Oncologia (ICO), L’Hospitalet de Llobregat, Barcelona, Spain
Article information
Full Text
Download PDF
Figures (2)
Background and objective

Five years’ data relative survival (RS) is presented in 3 solid tumours: breast, colorectal (CRC) and lung and 2 haematologic neoplasms: large B cell lymphoma (NHL-B) and multiple myeloma (MM) treated at Institut Català d’Oncologia between 2010 and 2011 in comparison with the results obtained in a historical special cohort from 1998 to 1999.

Material and methods

A database was created in a common safe and accessible repository. We have introduced more than 5,000 medical records. To analyze the results the statistical package R® was used for RS.


The overall RS at 5 years for 2010–2011 was: CRC 67%, breast 93.6%, lung 28%, NHL-B 68% and MM 62%, while for 1998–1999 is was: CRC 61.8%, breast 88.8%, lung 23.1%, NHL-B 67.7%, and MM 43.4%.


Comparative results have shown a 5% overall improvement in RS for the 3 solid tumours, a significant increase in MM and a stabilization in the NHL-B.

Survival results
Breast cancer
Colorectal cancer
Lung cancer
Fundamento y objetivo

Se presentan datos de supervivencia relativa (SR) (cociente entre la supervivencia observada y la esperada) a 5 años en las siguientes neoplasias: mama, pulmón, colorrectal (CCR), linfoma no Hodgkin de células grandes tipo B (LNHB) y mieloma múltiple (MM) tratados en el Institut Català d’Oncologia (ICO) en el período 2010-2011 y se comparan con los obtenidos en una cohorte especial histórica de los años 1998-1999.

Material y métodos

Para el segundo estudio, se creó una base de datos donde se introdujeron 5.000 registros con datos de la historia clínica. Para el análisis de resultados se utilizó el paquete estadístico R® para la SR.


Las SR globales a 5 años del segundo período (2010-2011) fueron: CCR 67%, mama 93,6%, pulmón 28%, LNHB 68,3% y MM 61,7% y para el primero (1998-1999) fueron: CCR 61,8%, mama 88,8%, pulmón 23,1%, LNHB 67,7% y MM 43,4%.


Se registró una mejoría de la SR, de alrededor del 5%, en los 3 tumores sólidos, un incremento significativo en el MM y una estabilización en los LNHB.

Palabras clave:
Resultados de supervivencia
Cáncer de mama
Cáncer colorrectal
Cáncer de pulmón


These are the options to access the full texts of the publication Medicina Clínica (English Edition)

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Medicina Clínica (English Edition)

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos